OPPM
PGEN icon

Opus Point Partners Management’s Precigen PGEN Stock Holding History

Opus Point Partners Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-32,284
Closed -$170K – 68
2019
Q1 		$170K Buy
32,284
+5,175
+19% +$35.9K 0.23% 74
2018
Q4 		$177K Buy
27,109
+3,329
+14% +$37.3K 0.39% 39
2018
Q3 		$409K Buy
23,780
+6,200
+35% +$92.2K 0.98% 32
2018
Q2 		$245K Sell
17,580
-898
-5% -$15.2K 0.53% 44
2018
Q1 		$283K Buy
18,478
+4,257
+30% +$60.9K 0.56% 39
2017
Q4 		$164K Sell
14,221
-9,707
-41% -$145K 0.14% 61
2017
Q3 		$455K Buy
23,928
+5,583
+30% +$115K 0.41% 53
2017
Q2 		$442K Sell
18,345
-66
-0.4% -$1.45K 0.4% 48
2017
Q1 		$365K Buy
18,411
+8,447
+85% +$189K 0.27% 63
2016
Q4 		$240K Buy
+9,964
New +$277K 0.19% 51

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Opus Point Partners Management's PGEN Position: Q2 2019 in Review

Opus Point Partners Management sold out of Precigen (PGEN) in Q2 2019, closing a stake of 32,284 shares — an estimated $170K sold.

Opus Point Partners Management first reported a position in PGEN in Q4 2016 and held it in 10 quarters. The position peaked at $455K in Q3 2017. 162 funds tracked by Wall St. Rank hold PGEN as of Q2 2019.

  • Opus Point Partners Management reported no remaining Precigen position as of Q2 2019 after selling out during the quarter.
  • Opus Point Partners Management sold 32,284 Precigen shares in Q2 2019, an estimated $170K.
  • Opus Point Partners Management first reported a position in Precigen in Q4 2016 and held it in 10 quarters.
  • Opus Point Partners Management's Precigen position peaked at $455K in Q3 2017.
  • 162 funds tracked by Wall St. Rank held Precigen as of Q2 2019.

Based on Opus Point Partners Management's 13F filing for Q2 2019, filed 14 Aug 2019.